001     120499
005     20240228145449.0
024 7 _ |a 10.1093/neuonc/now241
|2 doi
024 7 _ |a pmid:28391295
|2 pmid
024 7 _ |a 1522-8517
|2 ISSN
024 7 _ |a 1523-5866
|2 ISSN
024 7 _ |a altmetric:18694596
|2 altmetric
037 _ _ |a DKFZ-2017-00928
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Soffietti, Riccardo
|b 0
245 _ _ |a Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).
260 _ _ |a Oxford
|c 2017
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1661168423_30652
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The management of patients with brain metastases has become a major issue due to the increasing frequency and complexity of the diagnostic and therapeutic approaches. In 2014, the European Association of Neuro-Oncology (EANO) created a multidisciplinary Task Force to draw evidence-based guidelines for patients with brain metastases from solid tumors. Here, we present these guidelines, which provide a consensus review of evidence and recommendations for diagnosis by neuroimaging and neuropathology, staging, prognostic factors, and different treatment options. Specifically, we addressed options such as surgery, stereotactic radiosurgery/stereotactic fractionated radiotherapy, whole-brain radiotherapy, chemotherapy and targeted therapy (with particular attention to brain metastases from non-small cell lung cancer, melanoma and breast and renal cancer), and supportive care.
536 _ _ |a 315 - Imaging and radiooncology (POF3-315)
|0 G:(DE-HGF)POF3-315
|c POF3-315
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Abacioglu, Ufuk
|b 1
700 1 _ |a Baumert, Brigitta
|b 2
700 1 _ |a Combs, Stephanie E
|b 3
700 1 _ |a Kinhult, Sara
|b 4
700 1 _ |a Kros, Johan M
|b 5
700 1 _ |a Marosi, Christine
|b 6
700 1 _ |a Metellus, Philippe
|b 7
700 1 _ |a Radbruch, Alexander
|0 P:(DE-He78)77588f5b9413339755a66e739d316c7d
|b 8
|u dkfz
700 1 _ |a Villa Freixa, Salvador S
|b 9
700 1 _ |a Brada, Michael
|b 10
700 1 _ |a Carapella, Carmine M
|b 11
700 1 _ |a Preusser, Matthias
|b 12
700 1 _ |a Le Rhun, Emilie
|b 13
700 1 _ |a Rudà, Roberta
|b 14
700 1 _ |a Tonn, Joerg C
|b 15
700 1 _ |a Weber, Damien C
|b 16
700 1 _ |a Weller, Michael
|b 17
773 _ _ |a 10.1093/neuonc/now241
|g Vol. 19, no. 2, p. 162 - 174
|0 PERI:(DE-600)2094060-9
|n 2
|p 162 - 174
|t Neuro-Oncology
|v 19
|y 2017
|x 1523-5866
909 C O |p VDB
|o oai:inrepo02.dkfz.de:120499
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)77588f5b9413339755a66e739d316c7d
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-315
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Imaging and radiooncology
|x 0
914 1 _ |y 2017
915 _ _ |a Allianz-Lizenz / DFG
|0 StatID:(DE-HGF)0400
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEURO-ONCOLOGY : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b NEURO-ONCOLOGY : 2015
920 1 _ |0 I:(DE-He78)E012-20160331
|k E012
|l Neuroonkologische Bildgebung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)E012-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21